Results 21 to 30 of about 478,191 (158)

Association of alcohol consumption with all‐cause mortality, new‐onset stroke, and coronary heart disease in patients with abnormal glucose metabolism—Findings from a 10‐year follow‐up of the REACTION study 糖代谢异常患者饮酒与全因死亡率、新发卒中以及冠心病的关系——来自REACTION研究10年随访的发现

Journal of Diabetes, Volume 15, Issue 4, Page 289-298, April 2023., 2023
Highlights This long‐term longitudinal study demonstrates the association between alcohol consumption and health outcomes in patients with abnormal glucose metabolism including type 2 diabetes mellitus and prediabetes. Occasional drinking (less than once a week) reduces the risk of all‐cause mortality, while heavy alcohol consumption (≥30 g/day for men
Mengzhao Cui, Fei Li, Xiaokun Gang, Yuan Gao, Xianchao Xiao, Gang Wang, Yujia Liu, Guixia Wang   +7 more
wiley   +1 more source

Developing a prediction model for all‐cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China 中国上海地区建立的2型糖尿病患者全因死亡风险预测模型

Journal of Diabetes, Volume 15, Issue 1, Page 27-35, January 2023., 2023
Highlights This study constructed the first 5‐year all‐cause mortality risk prediction model for patients with type 2 diabetes mellitus in south China. This well‐performing model, using highly accessible predictors collected in routine clinical settings, provides a powerful tool for clinicians to identify high‐risk diabetic patients.
Jiying Qi, Ping He, Huayan Yao, Yanbin Xue, Wen Sun, Ping Lu, Xiaohui Qi, Zizheng Zhang, Renjie Jing, Bin Cui, Guang Ning   +10 more
wiley   +1 more source

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial 中国冠心病合并糖耐量异常患者的健康相关生活质量:一项随机、双盲、安慰剂对照试验的纵向分析

Journal of Diabetes, Volume 14, Issue 7, Page 455-464, July 2022., 2022
Highlights The Acarbose Cardiovascular Evaluation (ACE) trial assessed the effects of acarbose in patients with coronary heart disease (CHD) and impaired glucose tolerance (IGT) in China. Acarbose treatment did not impact on health‐related quality of life in ACE trial participants with CHD and IGT. Myocardial infarction (MI), stroke, heart failure, and
José Leal, Frauke Becker, Lee‐Ling Lim, Rury R. Holman, Alastair M. Gray   +4 more
wiley   +1 more source

Atherosclerotic disease burden after bariatric surgery in patients with obesity and type 2 diabetes 肥胖和2型糖尿病患者减肥手术后动脉粥样硬化疾病的负担

Journal of Diabetes, Volume 13, Issue 8, Page 640-647, August 2021., 2021
Highlights A nested, nationwide, propensity‐matched cohort study was carried out using the Clinical Practice Research Datalink with 1186 patients with no past history of ASCVD, half of whom had undergone bariatric surgery. Bariatric surgery was associated with improved ASCVD outcomes and lower mortality, highlighting a potential prognostic role of the ...
Maddalena Ardissino, Francesca Watson, Ravi Amin, Peter Collins, Osama Moussa, Sanjay Purkayastha, Imperial Obesity Study Group   +6 more
wiley   +1 more source

中国脑血管病临床管理指南（第2版）（节选）——第1章 概述 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition)(Excerpt)—Chapter One Overview

, 2023
《中国脑血管病临床管理指南（第2版）》是中国卒中学会组织专家根据近年来脑血管病领域研究的新进展、获取的新证据，对2019年第1版《中国脑血管病临床管理指南》进行的修订、补充和完善。该版指南涵盖脑血管病的全方位临床管理，包括卒中的组织化管理、高危人群管理、缺血性和出血性卒中以及脑静脉系统血栓形成的临床管理、卒中的康复管理等，旨在为从事卒中防治、护理、康复的相关专业人员和社会工作者，以及政府部门相关管理机构、卫生事业管理人员、医药企业、卫生保健需求方和其他利益相关者提供指导意见。 Abstract ...
谭泽锋，刘丽萍，徐安定，中国卒中学会中国脑血管病临床管理指南撰写工作委员会
core   +1 more source

Research on Named Entity Recognition of Electronic Medical Records Based on RoBERTa and Radical‐Level Feature

Wireless Communications and Mobile Computing, Volume 2021, Issue 1, 2021., 2021
Clinical named entity recognition (CNER) identifies entities from unstructured medical records and classifies them into predefined categories. It is of great significance for follow‐up clinical studies. Most of the existing CNER methods fail to give enough thought to Chinese radical‐level characteristics and the specialty of the Chinese field.
Yue Wu, Jie Huang, Caie Xu, Huilin Zheng, Lei Zhang, Jian Wan, Honghao Gao   +6 more
wiley   +1 more source

中国脑血管病临床管理指南（第2版）（节选）——第4章 缺血性脑血管病临床管理推荐意见 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt)——Chapter Four Clinical Management of Ischaemic Cerebrovascular Diseases

, 2023
我国的卒中发病率仍在持续上升，每年新发病例占全球的四分之一。在我国40岁及以上的人群中，缺血性卒中约占所有卒中类型的86.8%。自2019年中国脑血管病临床管理指南发布以来，缺血性卒中急性期再灌注治疗及二级预防抗血小板治疗等领域取得了多项进展。本指南就缺血性卒中急性期评估及诊断、再灌注治疗、抗血小板治疗、其他治疗、常规支持治疗及并发症管理、病因及发病机制的早期评估和诊断、针对病因和发病机制的干预、危险因素管理及长期干预更新推荐意见。 Abstract: The incidence of ...
刘丽萍，周宏宇，段婉莹，霍晓川，聂曦明，刘慧慧，，李子孝，徐蔚海，李淑娟，缪中荣，王拥军，中国卒中学会中国脑血管病临床管理指南撰写工作委员会
core   +1 more source

中国脑血管病临床管理指南（第2版）（节选）——第3章 脑血管病高危人群管理 Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Except) ——Chapter Three Management of Patients at Hige-risk of Cerebrovascular Diseases

, 2023
针对脑血管病的危险因素积极进行早期干预管理是减少脑血管病危害最有效的方法。本章节介绍脑血管病高危人群管理的推荐意见，包括对不可干预和可干预血管危险因素的控制，阿司匹林在缺血性卒中一级预防中的应用以及首次卒中风险评估等方面。 Abstract: Early intervention to manage the risk factors of cerebrovascular disease is the most effective way to reduce the harm of ...
王伊龙，陈玮琪，刘欣如，王文志，王永刚，王婷婷，王蓬莲，刘改芬，江滨，许予明，许玉园，许杰，孙冬玲，孙海欣，李子孝，李姝雅，杨沫，杨晓萌，杨营营，周梦圆，郑华光，宗黎霞，单舒乙，赵璟妍，茹小娟，姜勇，秦海强，贾茜，高远，梅延亮，曹勇，盖思齐，焦玉明，谢雪微，潘岳松，中国卒中学会中国脑血管病临床管理指南撰写工作委员会
core   +1 more source

Treatment and outcome of 370 cases with spontaneous or post‐laser twin anemia–polycythemia sequence managed in 17 fetal therapy centers

Ultrasound in Obstetrics &Gynecology, Volume 56, Issue 3, Page 378-387, September 2020., 2020
ABSTRACT Objective To investigate the antenatal management and outcome in a large international cohort of monochorionic twin pregnancies with spontaneous or post‐laser twin anemia–polycythemia sequence (TAPS). Methods This study analyzed data of monochorionic twin pregnancies diagnosed antenatally with spontaneous or post‐laser TAPS in 17 fetal therapy
L. S. A. Tollenaar, F. Slaghekke, L. Lewi, Y. Ville, M. Lanna, A. Weingertner, G. Ryan, S. Arévalo, A. Khalil, C. O. Brock, P. Klaritsch, K. Hecher, G. Gardener, E. Bevilacqua, K. V. Kostyukov, M. O. Bahtiyar, M. D. Kilby, E. Tiblad, D. Oepkes, E. Lopriore, Collaborators, J. M. Middeldorp, M. C. Haak, F. J. C. M. Klumper, J. Akkermans, H. Delagrange , V. Pandya, S. Faiola, R. Favre, S. R. Hobson, C. Rodo, B. Thilaganathan, R. Papanna, P. Greimel, M. Tavares de Sousa, A. Carlin, K. A. Gladkova, J. A. Copel   +37 more
wiley   +1 more source

Notch3基因突变在CADASIL 发病机制研究中的进展

Zhongguo shiyan zhenduanxue, 2022
随着我国人口老龄化加剧，脑血管病的发病率逐年提升，其中缺血性脑小血管病（SVD）是目前神经病学脑血管病研究的热点，与缺血性卒中和血管性痴呆密切相关，是成人血管性认知障碍的主要原因。SVD临床表现为皮质下多发腔隙性梗死和广泛的脑白质损伤。脑小血管疾病中最常见的遗传病因类型是常染色体显性遗传病合并皮质下梗死和白质脑病（CADASIL），由Notch3基因显性突变引起的，发病部位主要累及软脑膜和小穿通动脉。
徐雯琦, 李政, 南光贤
doaj